These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17263254)

  • 1. [Spasmodic dysphonia in course of Meige's syndrome--case report].
    Zalesska-Krecicka M; Morawska-Kochman M; Wierzbicka E; Skrzypek A; Krecicki T
    Otolaryngol Pol; 2006; 60(5):779-81. PubMed ID: 17263254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic aspects of spasmodic dysphonia.
    Rosenfield DB; Donovan DT; Sulek M; Viswanath NS; Inbody GP; Nudelman HB
    J Otolaryngol; 1990 Aug; 19(4):231-6. PubMed ID: 2213994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in Meige's syndrome.
    Yardimci N; Karatas M; Kilinc M; Benli S
    Acta Neurol Scand; 2006 Jul; 114(1):63-6. PubMed ID: 16774630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of botulinum toxin in Meige's disease.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Thompson AR
    J Ark Med Soc; 1994 Jan; 90(8):383-5. PubMed ID: 8175618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meige's syndrome: A cranial dystonia treated with bilateral pallidal deep brain stimulation.
    Markaki E; Kefalopoulou Z; Georgiopoulos M; Paschali A; Constantoyannis C
    Clin Neurol Neurosurg; 2010 May; 112(4):344-6. PubMed ID: 20061080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meige's syndrome and hemichorea associated with hyperthyroidism.
    Miao J; Liu R; Li J; Du Y; Zhang W; Li Z
    J Neurol Sci; 2010 Jan; 288(1-2):175-7. PubMed ID: 19883923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in Meige's syndrome: A video-based case series.
    Pandey S; Sharma S
    Neurol India; 2018; 66(1):71-76. PubMed ID: 29322963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry eye and Meige's syndrome.
    Tsubota K; Fujihara T; Kaido M; Mori A; Mimura M; Kato M
    Br J Ophthalmol; 1997 Jun; 81(6):439-42. PubMed ID: 9274405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spasmodic dysphonia.
    Rosenfield DB
    Adv Neurol; 1988; 49():317-27. PubMed ID: 3344634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Posterior laryngeal stenosis in patient with Meige's Syndrome].
    Pino Rivero V; Marcos García M; Trinidad Ruíz G; Pardo Romero G; González Palomino A; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(4):349-54. PubMed ID: 15382486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laryngeal dystonia--personal experience with botulin toxin treatment].
    Domzał TM; Tomczykiewicz K
    Neurol Neurochir Pol; 2002; 36(1):173-9. PubMed ID: 12053608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy-refractory schizophrenia in a patient who previously suffered from Meige's syndrome.
    Uemura T; Mochida M; Matsumi T; Yoshimoto K; Tatebayashi Y
    Neuropsychopharmacol Rep; 2019 Dec; 39(4):297-300. PubMed ID: 31743613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.